Please login to the form below

Not currently logged in
Email:
Password:

Digital intelligence blog

Pharma insight on digital marketing, social media, mobile apps, online video, websites and interactive healthcare tools

Sermo founders set up new online patient community

Par8o aims to foster greater collaboration between patients and their doctors

Two of the founders of US doctors' network Sermo have set up a new community to foster greater collaboration between patients and their doctors.

Par8o is the creation of Daniel Palestrant and Adam Sharp, until recently Sermo's CEO and chief medical officer respectively.

Introducing Par80, they said: “The current healthcare crisis is a uniquely American challenge and ultimately will be solved with a uniquely American solution. The most simple of solutions has yet to be attempted.

“Having built the largest physician community in the world, we've seen first-hand what is happening to our profession and understand what it is doing to our colleagues, and most importantly, our patients.

“We believe healthcare is best managed by direct collaboration between patients and the physicians providing their care.”

What this means in practice is a focus on improving the efficiency of the patient referral process. Referrals are “a critical moment in a patient's healthcare journey, either a change in diagnosis or an escalation in care”, Palestrant told Xconomy.

Ahead of a public launch planned for later this year Par8o remains invite-only.

The company is based in Cambridge, Massachusetts and its name is a play on the efficiency ideas of Italian economist Vilfred Pareto.

16th January 2012

From: Marketing

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Digitas Health

Digitas Health is the only digital-at-the-core brand agency designed to connect today's healthcare brands with today's healthcare consumers and professionals....

Latest intelligence

Genomics integration: can the NHS rise to the challenge?
Experts gather to discuss the UK’s genomic landscape...
London
“Brexit has been a catalyst for UK clinical research... it’s turbocharged change”
The UK clinical trials environment has been transformed in recent years – but can it really buck Brexit’s risks and uncertainties?...
The Future of Pharma sales: fast forward to 2029
Change is inevitable, and necessary, for growth in business....

Infographics